Neuroscience

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6)…

1 month ago

Clarivate Companies to Watch Report Spotlights Seven Women’s Health Startups Shaping the Future of Care

Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13,…

1 month ago

New Book Reveals 7 Science-Backed Strategies to Retrain Your Anxious Brain, Not Just Quiet It

Discover practical, science-backed strategies to retrain your anxious brain, build lasting calm, and reclaim control over stress and worry. EVERETT,…

1 month ago

Corundum Neuroscience Invests in NextSense to Support Commercialization of Smartbuds

TEL AVIV, Israel, Nov. 12, 2025 /PRNewswire/ -- Corundum Neuroscience (CNS), the neuroscience venture builder and fund announced today they have…

1 month ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

PLEASANTON, Calif., Nov. 11, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,…

1 month ago

Wearable Sensors Market to Reach $13.2 billion, Globally, by 2034 at 21.4% CAGR: Allied Market Research

The global wearable sensors market is experiencing rapid growth due to rise in integration of wearable sensors with smartphones and…

1 month ago

Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL

The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront M42,…

1 month ago

MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era

Boost memory, focus & mental clarity with MemoMaster – a clinically inspired brain supplement for sharper thinking, sustained energy &…

1 month ago

Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue

Interim data from the IQIRVO® (elafibranor) ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers…

1 month ago